Clinical trials
Phase 4 Bacterial Infections trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
47 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 2 |
| 2004 | 2 |
| 2006 | 6 |
| 2007 | 4 |
| 2008 | 4 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 5 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 34 |
| Recruiting | 5 |
| Terminated | 3 |
| Unknown status | 3 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Wyeth is now a wholly owned subsidiary of Pfizer | 4 |
| Merck Sharp & Dohme LLC | 3 |
| University of California, San Francisco | 3 |
| Emergent BioSolutions | 2 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| Thomas Benfield | 2 |
| Allergan | 1 |
| Bausch Health Americas, Inc. | 1 |
| Bayer | 1 |
| Bio Products Laboratory | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bacterial Infections | 47 |
| Infections | 9 |
| Sepsis | 4 |
| Chlamydia Infections | 3 |
| Eye Diseases | 3 |
| Eye Infections | 3 |
| Trachoma | 3 |
| Urinary Tract Infections | 3 |
| Anthrax | 2 |
| Diarrhea | 2 |
Trials
Showing 26 to 47 of 47. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.